Podcasts about screenings

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Linda Brubaker, MD, Deputy Editor of JAMA, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from June 21-27, 2025.

In this episode, we explore the motivations, findings, and clinical implications of a recent study examining patient understanding of the terms “sex” and “gender” in the context of prenatal testing, particularly non-invasive prenatal testing (NIPT).    “Patient understanding of fetal sex versus gender in the context of routine cell-free DNA screening”   Mindy Kolodziejski (she/her) is a Senior Genetic Counselor at University of Kentucky (UK) HealthCare and a graduate of the UTHealth Houston Genetic Counseling Program (UTGCP). She is the first author of "Patient understanding of fetal sex versus gender in the context of routine cell-free DNA screening," published in the Journal of Genetic Counseling, and presented this research at the National Society of Genetic Counselors (NSGC) conference in 2024. As a queer genetic counselor, Mindy is passionate about LGBTQIA+ issues in genetic counseling and strives to improve care, inclusion, and accessibility for transgender and gender-diverse (TGD) individuals. She also provides genetics services in the UK Differences of Sex Development (DSD) clinic. Connect with Mindy on LinkedIn: https://www.linkedin.com/in/mindy-kolodziejski-a07573186/   In this segment we discuss: - Why the terms sex and gender are different, but are often used interchangeably - Factors influencing patient understanding of sex and gender - Ways to help patients understand the information being presented while balancing being accurate and appropriate with the language being used - Specific content and approaches that can be added to prenatal education programs   Would you like to nominate a JoGC article to be featured in the show? If so, please fill out this nomination submission form here. Multiple entries are encouraged including articles where you, your colleagues, or your friends are authors.   Stay tuned for the next new episode of DNA Dialogues! In the meantime, listen to all our episodes Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Dialogues”.    For more information about this episode visit dnadialogues.podbean.com, where you can also stream all episodes of the show. Check out the Journal of Genetic Counseling here for articles featured in this episode and others.    Any questions, episode ideas, guest pitches, or comments can be sent into DNADialoguesPodcast@gmail.com.    DNA Dialogues' team includes Jehannine Austin, Naomi Wagner, Khalida Liaquat, Kate Wilson and DNA Today's Kira Dineen. Our logo was designed by Ashlyn Enokian. Our current intern is Sydney Arlen.

I think that this episode fits the "trifecta of true crime guests", if there ever was one. Phil is a profiler, podcast host, and author. He shared a lot of information, but there's way more to be found, by checking out his book (link below). So, check out some serial killer myths as they are exploded, and later, The Sherpa talks social media, and changes coming to Sherpalution ( none which involve tariffs, we promise). Thanks for coming on the show, Phil!. Follow Phil (not like a stalker, PLEASE!): Website: https://www.philchalmers.com/#/ Instagram: @philchalmersprofiler Facebook: @phil.chalmers.2025 .Here's the Amazon link to purchase "Speaking Truth To Evil" : https://www.amazon.com/Speaking-Truth-Evil-Surrounding-Killers-ebook/dp/B0F8P17TDG/ref=sr_1_1?crid=3KOZMG3H1X0U4&dib=eyJ2IjoiMSJ9.L_CMoFC7rsdyFcMHH4plHocfjW0bIVAurin5j-jpy5G-3RqEHw-IZa-mxGjgZxvKIE5Nxy1UbyGYCrfY2o-O4gOT_Jg2tqdFHdCoOIkHnccWBS5wRAEN2PSKEp6-csuCe543m8FuVrB1gsqGM9IHN_qp-L1mMMaNw_91XxgHeU5euxwil2gpio-_B4O85o7p_tTkhgEMZAHDgS2pAE3pZbmw_YllkG07Iox1Del0h00.MgbsOMYZbGyItzjYg7Yok3BwB8MwEqPIJGdDZfIFhSo&dib_tag=se&keywords=speaking+truth+to+evil&qid=1750523821&sprefix=speaking+truth%2Caps%2C86&sr=8-1 Programming note: Catch "Sherpa Selects" on Saturdays. It's the episodes you tried to avoid the first time around!Music Credits/Voiceovers: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Sherpa-lu Studio Players; Music from #Uppbeat (free for Creators!):https://uppbeat.io/t/goods-cargo/blurLicense code: SEGQXRLESQA3PHDZYouTube: @sherpalution5000 @sherpalution : social media for FB, IG, Bluesky, & TikTokLink page: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠bio.link/jimthepoHere's our website: https://shows.acast.com/the-sherpas-podcast-picksEmail:jimthepodcastsherpa@gmail.comSupport:Review the show on Apple Podcasts or Spotify Hosted on Acast. See acast.com/privacy for more information.

What could cost you your flying career? Not being prepared for your medical. Hosts Tait Duryea and Ryan Gibson welcome back Dan Monlux of Wingman Med to discuss how pilots can protect their FAA medical certificates. Dan breaks down what happens during a medical exam, the importance of primary care, and why early detection matters. This is a must-listen for pilots over 40 and anyone serious about staying in the skies.Dan Monlux is a retired Navy F-18 pilot and dual-trained physician in family and aerospace medicine. As co-founder of Wingman Med, he now helps pilots navigate complex FAA medical certification issues. With thousands of pilots successfully guided through the process, Dan combines flight experience and deep regulatory insight to keep aviators flying safely and confidently.Show notes:(0:00) Intro(03:29) The one test every pilot over 40 should do(06:25) Treat your medical like a checkride(08:09) Primary care vs. AME: What's the risk?(13:33) EKG tip that can save your exam(17:01) Why most AMEs can't coach you(20:43) ADHD, mental health, and new FAA standards(26:07) Screening tests to do by age group(32:02) MedExpress simulator and application tips(36:06) How to access your past FAA medicals(50:00) Outro

Send us a textDirected by award-winning filmmaker Cody Sheehy and produced by acclaimed Mark Monroe, The Last Dive is a visually stunning and emotionally resonant documentary that invites viewers to reflect on our connection to the natural world—and the wild, mysterious creatures that help us find our place in it. Support the show

In this episode, we welcome Alan Taylor. Alan is an Emmy-winning Director who has worked on shows including “The Sopranos,” “Six Feet Under,” “Sex in the City,” “The West Wing,” “Mad Men,” “Deadwood,” “Game of Thrones” and “House of the Dragon”. He's also directed films such as The Many Saints of Newark, Thor: The Dark World, and Terminator: Genisys. In our chat, he shares about his early days, cinematic inspirations, experiences on epic shows such as “The Sopranos,” working with James Gandolfini — plus many insights into his creative process and workflow.“The Making Of” is presented by AJA:Commercial shoots require speed and precision, which is why Dubai-based freelance editor Nikolay Ivanov depends on AJA's Io 4K Plus for fast, reliable I/O for on set editorial. Find out how he uses the technology alongside other creative tools to collaborate with stakeholders and deliver cuts while the camera is still rolling. Read the Story HereVimeo L.A. Event:Tuesday, June 24 | VidiotsA night of inspiring Vimeo Staff Picks + live filmmaker commentary!Join the Vimeo curation team as they screen recent Staff Picked films with live, unscripted commentary from some of the best creators on Vimeo.6:30pm Doors7:30-9pm Films + commentary 9-11pm Reception - complimentary drinks + bites!RSVP required. Screening and reception are free to attend!Register hereThunderbolt 5 Speed. Ultra Portable Storage.The OWC Envoy Pro Ultra the first portable SSD to harness the power of Thunderbolt 5, delivering real-world speeds over 6000MB/s in a rugged, pocket-sized design. With up to 4TB of capacity and next-gen bandwidth, it's built for high-res video, VFX, and demanding post-production workflows—anytime, anywhere. Lightweight, bus-powered, and blazing fast, it redefines what portable storage can do.Explore it hereNew Solutions from Videoguys:Now through June 30, 2025, get more value when you buy an Atomos monitor-recorder from Videoguys.com! Purchase a Ninja or Ninja Ultra and receive a FREE qualified 240GB SSD. Upgrade to a Shogun Classic, Shogun Ultra, or Sumo 19SE and get a FREE qualified 480GB SSD. To claim your free drive, simply buy from Videoguys.com and complete the mail-in rebate directly through Atomos.With five big reasons to go Atomos—record direct from the sensor, enable a direct-to-edit workflow, capture longer sessions, access pro monitoring tools, and share your shoot—this is the perfect time to upgrade. Act fast, this offer ends June 30, 2025! Call Videoguys at 800-323-2325 to find the right Atomos monitor-recorder for your workflow.Browse hereCheck out the ZEISS Otus ML:Now on sale, the Otus ML 1.4/50mm photography lens from ZEISS is the new generation of high-quality optics for your photographic art. Find it at your favorite photo retailer! Explore it herePodcast Rewind:June 2025 - Ep. 87…“The Making Of” is created by Michael Valinsky.Promote your products or services to over 200,000 filmmakers, TV production pros, and content creators reading this newsletter… contact us at mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

This week Sally and Lou explore themes of personal growth, self-care, and the complexities of relationships in the show business. They discuss the importance of taking a step back to focus on one's own journey, the 80-20 principle in energy management, and the challenges of navigating online criticism and misogyny. Also discussed are the aspects of bowel screening and a mishap involving a Tupperware container. If you want to get early access to the episodes, chat with Lou and Sally, send in your own drunk stories and much more then head over to www.patreon.com/spitorswallowpodcast   It's only £4 a month and it's a great way to support us so come and join the fun!   Follow us on Instagram @louandsally Learn more about your ad choices. Visit podcastchoices.com/adchoices

shownotes

This week, we present an inspiring episode for anyone interested in the history, present, and future of prostate cancer care. In this Legends in Urology installment of the BackTable Urology Podcast, Dr. Gerald Andriole joins guest host Dr. Niraj Badhiwala to reflect on a career that has left a lasting impact on the field. --- SYNPOSIS Dr. Andriole shares personal stories from his upbringing in Northeastern Pennsylvania and his journey into medicine. He reflects on his expedited education through Penn State and Jefferson Medical College and his path to urology. He discusses his pivotal work in prostate cancer screening, including the influence of major trials like The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, and traces the evolution of surgical and diagnostic techniques. The conversation also touches on current innovations and the future of prostate cancer management, offering valuable advice for the next generation of urologists. --- TIMESTAMPS 00:00 - Introduction01:59 - From Childhood to Medical School06:48 - Discovering Urology16:52 - Pioneering Prostate Cancer Screening24:07 - The PLCO Study: Design and Challenges28:57 - Controversies and Criticisms in Prostate Cancer Screening33:29 - Evolving Practices in Prostate Cancer Management44:19 - Future of Prostate Cancer Treatment

This week our spy on the inside gives us an EXCLUSIVE non spoiler Superman 2025 breakdown. Plus Eddie reviews the live action How to Train Your Dragon and Amazons Deep Cover and more..

- Screening SW original version brings mixed reactions- Filming for Starfighter- LISTENER EMAILSSUPPORT JON JUSTICE: https://ko-fi.com/jonjusticeOr PICK UP YOUR COPY OF THE EMBARK, SPACE OPERA SERIESAn exciting mix of Fast and Furious, Star Wars, Ready Player One and the sci-fi adventures of the 70's - 2000'sEMBARK: Book 1 and EMBARK: Treasure in Darkness (Book 2) EMBARK: The Vanishing War (Book 3) Gahan Corbijn and the Asteroid of Misfortune, The Rocket Queen (Book 5) Fear the Dangerous Night (Book 6) are available now in ebook, paperback, audiobook and free on Kindle Unlimited!EMBARK Battle Planet (Book 7) is now available!https://www.amazon.com/dp/B07K7LLFZYEmail: TalkShowNerd@gmail.com@X @JonJusticeInstagram TheJonJusticeFacebook Jon JusticeJoin the mailing list! TalkShowNerd@gmail.com

Matt is joined by Kevin Goetz, the CEO of Screen Engine/ASI, to discuss the world of test screenings. They dive into the importance of these test screenings, which filmmakers utilize the screenings (and which refuse), lessons learned while testing ‘Sinners,' how Kevin interprets the audience data, and the responsibility of communicating that data to the filmmakers (02:35). Matt finishes the show with opening weekend box office predictions for ‘28 Years Later' and Pixar's ‘Elio' (27:15). For a 20 percent discount on Matt's Hollywood insider newsletter, ‘What I'm Hearing ...,' ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠click here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Email us your thoughts! ⁠thetown@spotify.com⁠ Host: Matt Belloni Guest: Kevin Goetz Producers: Craig Horlbeck and Jessie Lopez Theme Song: Devon Renaldo Learn more about your ad choices. Visit podcastchoices.com/adchoices

Almost halfway through the season, and while I've been very happy with the guests that have been on so far, this episode is a real favorite. Kyndle was so much fun to talk with, and she has a really interesting story to tell, too! I'm sure her upcoming release will make a lot of people sit up and take notice of her immense talent. (And if they are already sitting up, they will stand! And do cartwheels! Too much? Sorry...) But as promised, here are some links where you can get a sample of Kyndle's earlier work, before her new album comes out. And I guarantee you, you'll be blown away like I was. Thanks for coming on the show, Kyndle!"Pour Some Sugar on Me": https://www.youtube.com/watch?v=ilClbWTYgfw"Say You'll Be There": https://www.youtube.com/watch?v=KWQzyl9fg1YKyndle on "CBS Mornings" :https://www.youtube.com/watch?v=tRzTw8TNfTsA Mix playlist of Kyndle: https://www.youtube.com/watch?v=6dyGpgm_BnU&list=PLjpduIqQCQvEhvWOmdqs1cCDYloTDZnWyKyndle on Facebook and Instagram: @kyndlewyldeWebsite (upcoming):www.kyndlewyldemusic.comCatch "Sherpa Selects" on Saturdays. It's the episodes you tried to avoid the first time around!More thanks: Music Credits/Voiceovers: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bruce Goldberg⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ( aka Lord Mr. Bruce); other Voices: The Sherpa-lu Studio PlayersYouTube: @sherpalution5000 @sherpalution : social media for FB, IG, Bluesky, & TikTokLink page: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠bio.link/jimthepoHere's our website: https://shows.acast.com/the-sherpas-podcast-picksEmail:jimthepodcastsherpa@gmail.comSupport:Review the show on Apple Podcasts or Spotify. Hosted on Acast. See acast.com/privacy for more information.

In this episode, we welcome Jessica Lee Gagné. Jessica is the cinematographer of the award-winning series, “Severance”. In our chat, she shares about her upbringing, early inspirations, and path to becoming a Director of Photography. She also sheds light on her longtime collaboration with Ben Stiller on both “Escape at Dannemora” and “Severance”. In addition, she talks about the tools and techniques used to capture this groundbreaking series — and offers invaluable advice for filmmakers today.“The Making Of” is presented by AJA:Commercial shoots require speed and precision, which is why Dubai-based freelance editor Nikolay Ivanov depends on AJA's Io 4K Plus for fast, reliable I/O for on set editorial. Find out how he uses the technology alongside other creative tools to collaborate with stakeholders and deliver cuts while the camera is still rolling. Read the Story HereVimeo L.A. Event:Tuesday, June 24 | Vidiots A night of inspiring Vimeo Staff Picks + live filmmaker commentary!Join the Vimeo curation team as they screen recent Staff Picked films with live, unscripted commentary from some of the best creators on Vimeo.6:30pm Doors7:30-9pm Films + commentary 9-11pm Reception - complimentary drinks + bites!RSVP required. Screening and reception are free to attend!Register hereThunderbolt 5 Speed. Ultra Portable Storage.The OWC Envoy Pro Ultra the first portable SSD to harness the power of Thunderbolt 5, delivering real-world speeds over 6000MB/s in a rugged, pocket-sized design. With up to 4TB of capacity and next-gen bandwidth, it's built for high-res video, VFX, and demanding post-production workflows—anytime, anywhere. Lightweight, bus-powered, and blazing fast, it redefines what portable storage can do.Explore it hereNew Solutions from Videoguys:Now through June 30, 2025, get more value when you buy an Atomos monitor-recorder from Videoguys.com! Purchase a Ninja or Ninja Ultra and receive a FREE qualified 240GB SSD. Upgrade to a Shogun Classic, Shogun Ultra, or Sumo 19SE and get a FREE qualified 480GB SSD. To claim your free drive, simply buy from Videoguys.com and complete the mail-in rebate directly through Atomos.With five big reasons to go Atomos—record direct from the sensor, enable a direct-to-edit workflow, capture longer sessions, access pro monitoring tools, and share your shoot—this is the perfect time to upgrade. Act fast, this offer ends June 30, 2025! Call Videoguys at 800-323-2325 to find the right Atomos monitor-recorder for your workflow. Browse hereOWC Announces Powerful New Updates to Jellyfish, Network-Attached Storage (NAS) SolutionsOther World Computing (OWC®), a trusted leader in high-performance storage, memory, connectivity, software, and accessories that empower creative and business professionals to maximize performance, enhance reliability, and streamline workflows, today announced the latest software release for its acclaimed OWC Jellyfish network-attached storage (NAS) solution. The new updates, designed specifically for video production teams, introduce a redesigned Jellyfish Manager and an all-new Jellyfish Media Manager, delivering smarter media workflows, deeper integrations, and unprecedented visibility into team activity and storage performance.Read more hereCheck out the ZEISS Otus ML:Now on sale, the Otus ML 1.4/50mm photography lens from ZEISS is the new generation of high-quality optics for your photographic art. Find it at your favorite photo retailer! Explore it herePodcast Rewind:June 2025 - Ep. 86…“The Making Of” is created by Michael Valinsky.Promote your products or services to 198K filmmakers, TV & broadcast production pros, and content creators reading this newsletter… email us at mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

In this episode, Medcan Chief Medical Officer Dr. Peter Nord sits down with Dr. Beth Abramson, Medcan's Director of Cardiology, to explore the latest innovations in cardiovascular screening. They discuss how two advanced assessments, ApoB and Lp(a), are transforming proactive heart health strategies, and how these tests are now part of Medcan's Annual Health Assessment. Plus, Dr. Abramson shares lifestyle tips every cardiologist wishes their patients would adopt. Highlights: Why Heart Health Matters: Heart disease is the second leading cause of death in Canada. 1 in 12 adults aged 20+ are living with diagnosed heart disease. Early detection through proactive screening is key to reducing long-term risk. What's New in Screening Tools: ApoB: A direct, precise blood biomarker that provides a better risk assessment than LDL cholesterol. Lp(a): A genetically determined lipoprotein that only needs to be measured once—and can identify cardiovascular risk even in otherwise healthy individuals. Both tests align with updated Canadian Cardiovascular Society guidelines, though they are not yet widely adopted across Canada. Medcan is leading the way in their implementation. How They Work: ApoB doesn't require fasting and is accurate even when LDL is low or triglycerides are high. Lp(a) is stable over time and can uncover hidden risks; early identification allows for better risk management and future intervention. New medications targeting Lp(a) are on the horizon, making this screening even more critical. Takeaways: Top Cardiologist-Recommended Lifestyle Tips for Heart Health: Prioritize regular physical activity Eat a diet rich in whole, unprocessed foods (vegetables, fruits, whole grains, lean protein, healthy fats) Maintain a healthy blood pressure and cholesterol level Avoid smoking and limit alcohol consumption These proactive steps, combined with Medcan's expanded screening tools, can help individuals manage their risk and promote long-term cardiovascular health. To learn more about how to support your heart, listen to the full episode. For personalized cardiovascular guidance, visit www.medcan.com.

Lucas Guilkey & JoeBill Muñoz | EP 370 In this powerful episode of Reza Rifts, host Keith Reza sits down with filmmakers Lucas Guilkey and JoeBill Muñoz to discuss their gripping documentary ‘The Strike' which sheds light on the harrowing hunger strikes at Pelican Bay Prison.   This conversation is a must-watch/listen for anyone passionate about documentary filmmaking, criminal justice reform, and human rights.     Website: https://www.thestrikefilm.com/   Support the show on https://patreon.com/rezarifts61  Follow Keith on all social media platforms: FB: https://www.facebook.com/realkeithreza IG:https://www.instagram.com/keithreza  X:https://www.twitter.com/keithreza  TT:https://www.tiktok.com/keithreza  Book Keith on cameo at www.cameo.com/keithreza Check out my website for dates at https://www.keithreza.com/ 

In this episode, Ken and Lisa of Watters Garden Center discuss the top 10 screening plants for windy locations. Check out the tall, robust plants, such as Red Tip Photinia and native Silverberry, that will help lessen the wind in your garden while also providing great privacy screening. Also, learn about diagnosing plant issues with Watters and get advice on watering new lawns.Listen to Mountain Gardener on Cast11: https://cast11.com/mountain-gardener-with-ken-lain-gardening-podcast/Follow Cast11 on Facebook: https://Facebook.com/CAST11AZFollow Cast11 on Instagram: https://www.instagram.com/cast11_podcast_network/

This week, Joe Shearer joins me to review DreamWorks' live-action remake, How to Train Your Dragon in a feature review and then, in this week's secondary review, I share my thoughts on the new AppleTV+ original movie, Echo Valley. We also discuss recent movie and TV news, screenings around Indianapolis, and more. Timestamps Show Start - 00:28 Introducing Joe - 02:15 Screening in Indy - 08:02 News Before the Reviews - 17:51 Feature Review How to Train Your Dragon (2025) - 33:29 Spoiler - 1:13:55 Exit Joe - 1:41:06 Secondary Review Echo Valley (2025) - 1:46:25 Closing the Ep - 2:03:57 Patreon Clip - 2:05:36 Related Links Tower Junkies - 096 - Movie - The Life of Chuck (2025) - Guest: Kim C (The Year of Underrated Stephen King) Mia Goth Joins Ryan Gosling In ‘Star Wars: Starfighter' ‘Mass Effect': Doug Jung Joins Amazon's Series Adaptation Of Video Game As Showrunner   Joe's Letterboxd Joe's Writing on Midwest Film Journal Joe's Review of How to Train Your Dragon (2025) Joe's Review of Fight or Flight (2025) Joe's Review of The Surfer (2025)   My 2025 Podcast and Writing Archive Patreon Special - 28 Days Later (2002) at Alamo Drafthouse - May 23, 2025 Immediate Reaction - Clown in a Cornfield (2025) - May 16-21, 2025 Immediate Reaction - The Life of Chuck (2025) - May 29, 2025 Patreon Companion Episodes Collection Companion Ep - OV477 - Final Destination 1-5 Retrospective - May 24-25, 2025 Patreon - Severance Episode Reviews   Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse   Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS   Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd   Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.5.4) Joe: Tonor USB Microphone via Google Meet   Episode Homepage: ObsessiveViewer.com/OV479   Next Week on the Podcast OV480 - Materialists (2025 & Ballerina (2025)  

The Art of Filmmaking: Behind the Scenes with Josh Segundo - Get Reelisms Podcast #157 Join hosts Adam Chase Rani and Christine Chen in Episode 157 of the Get Reelisms Podcast as they dive deep into the world of filmmaking! This episode features an insightful conversation with Josh, a writer-director who shares his experiences and challenges in making short films. They discuss the importance of preparation, the complexities of crowdfunding, working with friends, and the nuances of shooting during the pandemic. Josh reflects on his latest project 'Where Do We Go?' and offers valuable advice for aspiring filmmakers. Tune in for secrets, advice, and filmmaking gossip!  Hosts: Adam Rani (@adamthechase)   & Christine Chen (@cchenmtf) Guest: Josh Segundo For more information about Christine Chen: christinewchen.comFor more information go to getreelisms.com For more information on ERZULIE go to: erzuliefilm.com  WEBISODE version of the Podcastgetreelisms.com 00:00 Introduction to the Get Reelisms Podcast 00:21 Meet the Hosts and Guest 00:43 Sports Talk and Personal Stories 02:39 Filmmaking Secrets and Advice 04:25 Guest's Filmmaking Journey 05:07 Crowdfunding Challenges 06:31 Production Insights and Challenges 18:40 Post-Production Reflections 21:35 Reflections on the Short Film 22:02 Navigating Film Festivals 22:44 Dealing with Vulnerability and Screenings 24:39 Pandemic Influence and Nostalgia 27:39 Inspiration and Cinematic Techniques 29:59 Future Projects and Filmmaking Philosophy 37:12 The Importance of Collaboration 42:59 Challenges and Rewards of Filmmaking 48:47 Final Thoughts and Encouragement Official Get Reelisms PageGet Reelisms Amazon StoreInstagram

Pregnancy comes with a long list of new things - and routine blood tests and ultrasounds are high on that list. But what are they all actually for?In this short and sweet Call the Midwife episode, we break down the key routine tests offered throughout pregnancy, what they check for, and why they matter - minus the jargon and stress.We cover:First trimester bloods: What's included and what they're screening forGenetic screening options (like NIPT and combined first trimester screening)Iron, vitamin D, blood group, antibodies and moreGlucose tolerance testing (GTT): What to expect around 26–28 weeksRoutine ultrasounds: Dating scan, nuchal translucency, morphologyThe role of informed consent and your right to ask questions at every stepWhether you're newly pregnant or just want to feel more informed, this is a great starting point to understand what's being tested - and why.Sponsored by SleepybellyLet's be honest: pregnancy sleep can be a bit… tricky. That's why we love Sleepybelly - the ultimate pregnancy pillow that supports your bump, back and hips, so you can finally rest easy. It's designed by parents and trusted by health professionals.Use the code GROWING10 for 10% off and enjoy a 30-night risk-free trial at sleepybelly.com.auThanks for tuning in - and don't forget to share this episode with a fellow parent-to-be.

On this episode of THE GEEK BUDDIES, John Rocha and Michael Vogel discuss the big entertainment news of the week includin: - Andor's Nielsen numbers - Spaceballs 2 is a go! - Kathleen Kennedy updates with Star Wars - Annecy News: Mister Miracle, dc animated slate, Incedibles and the new movie info coming out of Annecy. Remember to Like and Share this episode on your social media and to Subscribe to The Outlaw Nation YouTube channel below. #marvel #DC #StarWars #thegeekbuddies ____________________________________________________________________________________ Chapters: 0:00 Intro and Rundown 3:54 Spaceballs 2 Is Happening with Rick Moranis Returning! 12:22 ANDOR S2 Finale Tops Nielsen Streaming Charts 22:17 Kathleen Kennedy Attends BFI's Screening of Original Star Wars Film 27:04 Kathleen Kennedy Talks the Future of Star Wars 34:20 DC Studios Animation Updates- Mister Miracle, Super Powers, Green Lantern 42:58 Annecy PIXAR Presentation- Toy Story 5, Zootopia 2, Gatto, Elio Footage 46:30 Peter Sohn to Direct Incredibles 3 57:04 James Gunn's EW Interview - Wonder Woman, The Batman 2, World's Finest 1:07:31 New SUPERMAN Trailer Breakdown - Did It Quiet Skeptics? 1:18:57 Star Trek: Strange New Worlds Will End with a Truncated 5th Season 1:23:22 Streamlabs and Superchat Questions FOLLOW THE GEEK BUDDIES: Twitter: https://twitter.com/Geek_Buddies Follow John Rocha: https://twitter.com/TheRochaSays​​​​​ Follow Michael Vogel: https://twitter.com/mktoon Follow Shannon McClung: https://twitter.com/Shannon_McClung Learn more about your ad choices. Visit megaphone.fm/adchoices

See omnystudio.com/listener for privacy information.

In this episode, we welcome Stefani Robinson. Stefani is a 6x Emmy-nominated Writer/Producer, who has worked on shows including “Atlanta,” “Fargo,” “What We Do in the Shadows” and “Adults”. In our chat, she shares her upbringing, early inspirations, pathway into television, and experiences working on a variety of hit shows. She also provides a healthy dose of inspiration and advice for up-and-coming creators. “The Making Of” is presented by AJA:Commercial shoots require speed and precision, which is why Dubai-based freelance editor Nikolay Ivanov depends on AJA's Io 4K Plus for fast, reliable I/O for on set editorial. Find out how he uses the technology alongside other creative tools to collaborate with stakeholders and deliver cuts while the camera is still rolling. Read the Story HereVimeo L.A. Event:A night of inspiring Vimeo Staff Picks + live filmmaker commentary!Join the Vimeo curation team as they screen recent Staff Picked films with live, unscripted commentary from some of the best creators on Vimeo.6:30pm Doors7:30-9pm Films + commentary 9-11pm Reception - complimentary drinks + bites!RSVP required.Screening + reception are free to attend! Register hereThunderbolt 5 Speed. Ultra Portable Storage.The OWC Envoy Pro Ultra the first portable SSD to harness the power of Thunderbolt 5, delivering real-world speeds over 6000MB/s in a rugged, pocket-sized design. With up to 4TB of capacity and next-gen bandwidth, it's built for high-res video, VFX, and demanding post-production workflows—anytime, anywhere. Lightweight, bus-powered, and blazing fast, it redefines what portable storage can do.Explore it hereNew Solutions from Videoguys:Now through June 30, 2025, get more value when you buy an Atomos monitor-recorder from Videoguys.com! Purchase a Ninja or Ninja Ultra and receive a FREE qualified 240GB SSD. Upgrade to a Shogun Classic, Shogun Ultra, or Sumo 19SE and get a FREE qualified 480GB SSD. To claim your free drive, simply buy from Videoguys.com and complete the mail-in rebate directly through Atomos.With five big reasons to go Atomos—record direct from the sensor, enable a direct-to-edit workflow, capture longer sessions, access pro monitoring tools, and share your shoot—this is the perfect time to upgrade. Act fast, this offer ends June 30, 2025! Call Videoguys at 800-323-2325 to find the right Atomos monitor-recorder for your workflow. Browse hereCheck out the ZEISS Otus ML:Now on sale, the Otus ML 1.4/50mm photography lens from ZEISS is the new generation of high-quality optics for your photographic art. Find it at your favorite photo retailer! Explore it hereFeatured Film Festival: The 14th Evolution Mallorca International Film Festival (EMIFF) celebrates its eighth consecutive year on MovieMaker Magazine's prestigious “50 Film Festivals Worth the Entry Fee” list for 2025. Set in beautiful Palma de Mallorca, EMIFF stands out for its vibrant international community and commitment to bridging cultures through film. This year, the festival proudly presents its unique 4th annual Cinematography Focus, dedicated to honoring the art and craft of cinematography with special screenings, panels, and masterclasses. With its filmmaker-friendly atmosphere, stunning Mediterranean backdrop, and dedication to innovation and diversity, EMIFF is a must-enter festival for storytellers seeking inspiration, connection, and industry recognition. Learn more hereLast Submission Deadlines: July 6th and August 6th, 2025.Festival Dates: October 21st - 29th, 2025.Podcast Rewind:June 2025 - Ep. 85…“The Making Of” is created by Michael Valinsky.Promote your products or services to 190K filmmakers, broadcast production pros, and content creators reading this newsletter… email us at mvalinsky@me.com Get full access to The Making Of at themakingof.substack.com/subscribe

The director receives the Made in NY award at the Tribeca Festival

Disney and Universal are suing AI image and video generator Midjourney With just a couple of sentences you can create your own scene starring Homer Simpson, a Minion, or a Star Wars character. That's cool, but a problem for the studios who own the IP for that content. The studios call Midjourney a “virtual vending machine” and “bottomless pit of plagiarism” in their suit. Many of these AI companies have been using copyrighted material under "fair use" provisions to train their models, but this lawsuit directly challenges that. The lawsuit seeks damages ($150,000 per infringement) and an injunction that would immediately stop Midjourney's operations. Apple is bringing Call Screening to iOS26 Why are you calling me? That's the question the caller will now need to answer before you decide to pick up. Not interested, ignore them! This builds on the "live voicemail" feature they already rolled out. With this update, telemarketers will need to explain themselves before you answer! Spam calls are a real problem in the USA, so this will come as a welcome relief for many. CarPlay can now be customized for car makers Aston Martin is Apple's first CarPlay Ultra customer. The two collaborated to bring Apple Car Play to the driver's dashboard. So now your maps, music controls and more will be right there, not off to the side screen. But the main CarPlay screen will now have car control capabilities such as air vents, temperature, and driving preferences. It brings the Tesla style experience to more automakers. LISTEN ABOVE See omnystudio.com/listener for privacy information.

The director receives the Made in NY award at the Tribeca Festival

In this episode, PJ Barclay, President and CEO of Impirica, shares his journey from the world of accounting to tackling impairment in the trucking industry. After recognizing the need for better safety measures, PJ explains how cognitive science and technology came together to create solutions for improving driver wellness and safety.He and Jeremy discuss the broader issue of impairment, addressing factors like fatigue, mental health, and other conditions that impact a driver's ability to perform safely. PJ also reveals how Impirica's technology is helping the industry proactively measure impairment risk and enhance safety standards.This conversation is all about pushing boundaries in safety, embracing innovation, and understanding the human side of the issue. If you're curious about how cognitive science and technology are shaping the future of trucking safety, this episode will give you plenty to think about.

Well, I don't know about YOU, but President Trump has big weekend plans: On Saturday, he's going to be enjoying a military parade in honor of the 250th anniversary of the Army, which also happens to fall on his birthday. There are hundreds of protests planned in cities across the country as counter-programming to this parade. They're organized under the umbrella of the "No Kings" theme. That includes here in Washington State, and the No Kings website says 80 protests are planned in places from Anacortes to Walla Walla. The Kitsap Sun has a list of where those are happening on Saturday and how to stay safe at KitsapSun.com But not to worry, there are a TON of other weekend events coming up: LINKS: Black Night Market — Friends of Waterfront Park Brass Screw Consortium - Port Townsend Maple Valley Days - Lake Wilderness Park An Evening with John Cusack & Screening of "High Fidelity" - Tacoma Seattle Flying Dragon Boat Club - South Lake Union Park Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Understanding the ins and outs of driver testing and background checks can make all the difference in a trucking career. For Marc Bourne and Grady Phillips, supporting drivers means building trust through transparency and clear communication around testing and background screening.  In this episode, Chelsea Faulkner sits down with Marc Bourne, Vice President of Background Screening, Training, and Compliance Services at Workforce QA, and Grady Phillips, CRO at Workforce QA, who both bring a unique background to trucking, to explore how testing processes can be fair, straightforward, and driver-friendly. They discuss how companies can move beyond just ticking boxes to fostering honest, respectful relationships. You'll hear them bust common myths about drug and background testing, explain why drivers should take charge of their own records, and share how ongoing education and advocacy help create a safer, better-informed trucking community. Marc and Grady stress the importance of treating drivers like people and giving them clarity about what's tested and why it matters. In this episode, you'll hear about: Why trust is the foundation of driver testing and records How to advocate for yourself with MVR, PSP, and background checks How digitization can improve the hiring process Resources: Grady Phillips on LinkedIn Marc Bourne on LinkedIn HandledNow Website HandledNow on Facebook Chelsea on LinkedIn Episode highlights: (00:00) Intro and background of Marc Bourne and Grady Phillips (00:07:00) Why trust matters between drivers and companies (00:14:00) The power of clear communication and candidate experience (00:16:00) Debunking common myths about background checks (00:22:30) Understanding MVR, PSP, and clearinghouse records (00:32:00) Keeping up with policy changes and regulations (00:37:00) How digital tools are changing testing and record keeping (00:39:00) Rapid fire: driver questions and redesigning testing (00:43:00) Making drivers feel supported, not singled out (00:44:30) How to connect with Marc and Grady

In the U.S., approximately 3.6 million people are threatened by eviction each year, and for many, the consequences last long after the eviction itself. Even if individuals avoid losing their homes, eviction records can prevent them from securing future housing. This happens because landlords use tools that screen the rental, credit, employment, income and criminal histories of tenants—often without context or accuracy.In this sponsored episode produced in partnership with Results for America, we discuss a proven solution: tenant screening protections. We explore how these safeguards can protect renters by ensuring fair access to housing, and we learn how communities can implement these protections to help more people secure stable homes.Guests on this episode include Brittany Giroux Lane, Director of the Solutions Accelerator at Results for America, Marie Claire Tran-Leung, Evictions Initiative Project Director at the National Housing Law Project, and Rasheedah Phillips, Director of Housing at PolicyLink. They dive into the importance of tenant screening protections and how these initiatives can help create more equitable access to housing.

The Big Unlock Podcast · Scaling With Autonomous AI for Diabetic Retinopathy Screening – Podcast with Alvin Liu In this episode, Dr. T.Y. Alvin Liu, Inaugural Director, James P Gills Jr MD and Heather Gills AI Innovation Center at Johns Hopkins Medicine shares his journey in healthcare AI, with a focus on image analysis and real-world applications. Dr. Liu discusses the FDA-approved autonomous AI system for diabetic retinopathy screening, which enables early detection in primary care settings and improves screening adherence. He outlines successful AI implementations at Johns Hopkins, including prior authorization pilots using generative AI and the importance of operational understanding in deployment. He also discussed the intersection of value-based medicine and artificial intelligence, and the challenges of implementing successful AI programs.  At the enterprise level, Dr. Liu emphasizes the need for strong AI governance to assess safety, effectiveness, and ROI. He outlines key challenges for AI startups, especially around reimbursement and regulation, and urges them to pursue sustainable business models. He also suggests closer collaboration among startups, VCs, and integrated health systems to bridge the gap between innovation and real-world adoption, essential for scaling AI responsibly and delivering long-term value in healthcare. Take a listen.

On this episode of Chit Chat Stocks, we research Joel Greenblatt and what we can learn from the investor who put up 50% annualized returns before fees for Gotham Capital. We discuss:(02:55) Who is Joel Greenblatt?(08:34) Gotham Capital's Performance(11:36) Special Situations Investing(12:34) Understanding Spin-Offs(19:30) Mergers and Arbitrage(23:35) Bankruptcies and Restructurings(32:35) Recapitalizations, Options, and Leaps(36:19) Understanding the Little Book: Quality Stocks at Cheap Prices(41:11) Screening for Value: EV to EBIT and ROIC(49:13) The Magic Formula: Combining Quality and Value(57:59) Lessons from Joel Greenblatt: Complexity and Homework*****************************************************JOIN OUR NEWSLETTER AND FREE CHAT COMMUNITY: https://chitchatstocks.substack.com/ *********************************************************************Chit Chat Stocks is presented by Interactive Brokers. Get professional pricing, global access, and premier technology with the best brokerage for investors today: https://www.interactivebrokers.com/ Interactive Brokers is a member of SIPC. *********************************************************************FinChat.io is the complete stock research platform for fundamental investors.With its beautiful design and institutional-quality data, FinChat is incredibly powerful and easy to use.Use our LINK and get 15% off any premium plan: ⁠finchat.io/chitchat *********************************************************************Bluechippers Club is a tight-knit community of stock focused investors. Members share ideas, participate in weekly calls, and compete in portfolio competitions.To join, go to ⁠Blue Chippers and apply! Link: ⁠https://bluechippersclub.com/*********************************************************************Disclosure: Chit Chat Stocks hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation.

Our top news stories: The new "Superman" movie is now fully finished, early screening tickets for the new movie went on sale for Amazon Prime members, and "Lois & Clark" is finally coming to blu-ray. Superman news for the period June 4-10, 2025. Brought to you by SupermanHomepage.com. Hosted by Steve Younis. Visit our website: https://www.SupermanHomepage.com/ Visit our online store: https://www.SupermanHomepage.com/shop Featured Products and Links: "Superman" 2025 Movie Merchandise - https://amzn.to/3AdxENy Supergirl (Series #8) 1:10 Scale Statue by Iron Studios - https://www.supermanhomepage.com/pre-order-your-supergirl-110-scale-statue-by-iron-studios/ "Superman" Movie Decals, Stickers, License Plate Covers, Keychains and More! - https://www.supermanhomepage.com/superman-movie-decals-stickers-license-plate-covers-keychains-and-more/ "Superman" Movie Wall Posters - https://www.supermanhomepage.com/superman-movie-wall-posters/ This week's Superman comic books - https://www.supermanhomepage.com/superman-comic-books-available-this-week-june-11-2025/ Latest Comic Book Reviews - https://www.supermanhomepage.com/comics/2025-comic-reviews/c-review-2025.php

Did you get your Amazon prime superman preview tickets? 2025 Summer blockbuster showdown between Superman, Fantastic Four , and Jurassic Park! Joey shows us his Nintendo Switch 2, And much more We discuss on the Geek Culture Congress Podcast! Listen to our podcast on Bpodstudios.com or wherever you get your podcasts! Please give us a like, comment or share if you like the show! Follow us on Instagram @geekculturecongress Also tell your smart speaker to "play geek culture congress podcast" anytime! Don't miss our live show NOW EVERY TUESDAY 8:30pm EST on Youtube at @speedysmultiverse Youtube: https://www.youtube.com/@speedysmultiverse

What if everything we believe about finding love is designed to keep us searching instead of finding? This episode debunks some of the worst common advice and showcases what's genuinely useful. It might start with you. The people most focused on finding the perfect partner often remain alone, while those focused on becoming the right partner tend to attract extraordinary relationships. Shift from scarcity-based dating to abundance-based connection: Understand "optimal search theory" Focus on shared vision for the future rather than identical current interests Recognise that generosity and a growth mindset matter more than initial chemistry If you find someone, will you recognise them when you do? Advertiser - Millionaire Match High-quality, entrepreneurial singles, for serious relationships MillionaireMatch.com Referal code 'GROW' for a welcome treat. NEW SHOW - How to Change the World Sam's new show can be found on major podcast players: Spotify - ⁠⁠⁠⁠⁠⁠https://open.spotify.com/show/1Fj3eFjEoAEKF5lWQxPJyT⁠⁠⁠⁠⁠⁠ Apple - ⁠⁠⁠⁠⁠⁠https://podcasts.apple.com/us/podcast/how-to-change-the-world-the-history-of-innovation/id1815282649⁠⁠⁠⁠⁠⁠ YouTube - ⁠⁠⁠⁠⁠⁠https://www.youtube.com/@HowToChangeTheWorldPodcast⁠⁠⁠⁠⁠⁠ Can't find it on your player? RSS feed - ⁠⁠⁠⁠⁠⁠https://feeds.acast.com/public/shows/682b3b86696b5d1232d698a8⁠⁠⁠⁠⁠⁠ ------- UPGRADE to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Premium⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠:

Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and screening processes. Transcript Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational Book. I'm Dr. Nate Pennell, the co-director of the Cleveland Clinic Lung Cancer Program and vice chair of clinical research for the Taussig Cancer Center. I'm also the editor-in-chief for the ASCO Educational Book.  Lung cancer is one of the leading causes of cancer-related mortality worldwide, and most cases are diagnosed at advanced stages where curative treatment options are limited. On the opposite end, early-stage lung cancers are very curable. If only we could find more patients at that early stage, an approach that has revolutionized survival for other cancer types such as colorectal and breast cancer.  On today's episode, I'm delighted to be joined by Dr. Cheryl Czerlanis, a professor of medicine and thoracic medical oncologist at the University of Wisconsin Carbone Cancer Center, to discuss her article titled, "Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening." The article was recently published in the ASCO Educational Book and featured in an Education Session at the 2025 ASCO Annual Meeting. Our full disclosures are available in the transcript of this episode.  Cheryl, it's great to have you on the podcast today. Thanks for being here. Dr. Cheryl Czerlanis: Thanks, Nate. It's great to be here with you. Dr. Nate Pennell: So, I'd like to just start by asking you a little bit about the importance of lung cancer screening and what evidence is there that lung cancer screening is beneficial. Dr. Cheryl Czerlanis: Thank you. Lung cancer screening is extremely important because we know that lung cancer survival is closely tied to stage at diagnosis. We have made significant progress in the treatment of lung cancer, especially over the past decade, with the introduction of immunotherapies and targeted therapies based on personalized evaluation of genomic alterations. But the reality is that outside of a lung screening program, most patients with lung cancer present with symptoms related to advanced cancer, where our ability to cure the disease is more limited.  While lung cancer screening has been studied for years, the National Lung Screening Trial, or the NLST, first reported in 2011 a significant reduction in lung cancer deaths through screening. Annual low-dose CT scans were performed in a high-risk population for lung cancer in comparison to chest X-ray. The study population was comprised of asymptomatic persons aged 55 to 74 with a 30-pack-year history of smoking who were either active smokers or had quit within 15 years. The low-dose CT screening was associated with a 20% relative risk reduction in lung cancer-related mortality. A similar magnitude of benefit was also reported in the NELSON trial, which was a large European randomized trial comparing low-dose CT with a control group receiving no screening. Dr. Nate Pennell: So, this led, of course, to approval from CMS (Centers for Medicare and Medicaid Services) for lung cancer screening in the Medicare population, probably about 10 years ago now, I think. And there are now two major trials showing an unequivocal reduction in lung cancer-related mortality and even evidence that it reduces overall mortality with lung cancer screening. But despite this, lung cancer screening rates are very low in the United States. So, first of all, what's going on? Why are we not seeing the kinds of screening rates that we see with mammography and colonoscopy? And what are the barriers to that here? Dr. Cheryl Czerlanis: That's a great question. Thank you, Nate. In the United States, recruitment for lung cancer screening programs has faced numerous challenges, including those related to socioeconomic, cultural, logistical, and even racial disparities. Our current lung cancer screening guidelines are somewhat imprecise and often fail to address differences that we know exist in sex, smoking history, socioeconomic status, and ethnicity. We also see underrepresentation in certain groups, including African Americans and other minorities, and special populations, including individuals with HIV. And even where lung cancer screening is readily available and we have evidence of its efficacy, uptake can be low due to both provider and patient factors. On the provider side, barriers include having insufficient time in a clinic visit for shared decision-making, fear of missed test results, lack of awareness about current guidelines, concerns about cost, potential harms, and evaluating both true and false-positive test results.  And then on the patient side, barriers include concerns about cost, fear of getting a cancer diagnosis, stigma associated with tobacco smoking, and misconceptions about the treatability of lung cancer. Dr. Nate Pennell: I think those last two are really what make lung cancer unique compared to, say, for example, breast cancer, where there really is a public acceptance of the value of mammography and that breast cancer is no one's fault and that it really is embraced as an active way you can take care of yourself by getting your breast cancer screening. Whereas in lung cancer, between the stigma of smoking and the concern that, you know, it's a death sentence, I think we really have some work to be made up, which we'll talk about in a minute about what we can do to help improve this.  Now, that's in the U.S. I think things are probably, I would imagine, even worse when we leave the U.S. and look outside, especially at low- and middle-income countries. Dr. Cheryl Czerlanis: Yes, globally, this issue is even more complex than it is in the United States. Widespread implementation of low-dose CT imaging for lung cancer screening is limited by manpower, infrastructure, and economic constraints. Many low- and middle-income countries even lack sufficient CT machines, trained personnel, and specialized facilities for accurate and timely screenings. Even in urban centers with advanced diagnostic facilities, the high screening and follow-up care costs can limit access. Rural populations face additional barriers, such as geographic inaccessibility of urban centers, transportation costs, language barriers, and mistrust of healthcare systems. In addition, healthcare systems in these regions often prioritize infectious diseases and maternal health, leaving limited room for investments in noncommunicable disease prevention like lung cancer screening. Policymakers often struggle to justify allocating resources to lung cancer screening when immediate healthcare needs remain unmet. Urban-rural disparities exacerbate these challenges, with rural regions frequently lacking the infrastructure and resources to sustain screening programs. Dr. Nate Pennell: Well, it's certainly an intimidating problem to try to reduce these disparities, especially between the U.S. and low- and middle-income countries. So, what are some of the potential solutions, both here in the U.S. and internationally, that we can do to try to increase the rates of lung cancer screening? Dr. Cheryl Czerlanis: The good news is that we can take steps to address these challenges, but a multifaceted approach is needed. Public awareness campaigns focused on the benefits of early detection and dispelling myths about lung cancer screening are essential to improving participation rates. Using risk-prediction models to identify high-risk individuals can increase the efficiency of lung cancer screening programs. Automated follow-up reminders and screening navigators can also ensure timely referrals and reduce delays in diagnosis and treatment. Reducing or subsidizing the cost of low-dose CT scans, especially in low- or middle-income countries, can improve accessibility. Deploying mobile CT scanners can expand access to rural and underserved areas.  On a global scale, integrating lung cancer screening with existing healthcare programs, such as TB or noncommunicable disease initiatives, can enhance resource utilization and program scalability. Implementing lung cancer screening in resource-limited settings requires strategic investment, capacity building, and policy interventions that prioritize equity. Addressing financial constraints, infrastructure gaps, and sociocultural barriers can help overcome existing challenges. By focusing on cost-effective strategies, public awareness, and risk-based eligibility criteria, global efforts can promote equitable access to lung cancer screening and improve outcomes.  Lastly, as part of the medical community, we play an important role in a patient's decision to pursue lung cancer screening. Being up to date with current lung cancer screening recommendations, identifying eligible patients, and encouraging a patient to undergo screening often is the difference-maker. Electronic medical record (EMR) systems and reminders are helpful in this regard, but relationship building and a recommendation from a trusted provider are really essential here. Dr. Nate Pennell: I think that makes a lot of sense. I mean, there are technology improvements. For example, our lung cancer screening program at The Cleveland Clinic, a few years back, we finally started an automated best practice alert in our EMR for patients who met the age and smoking requirements, and it led to a six-fold increase in people referred for screening. But at the same time, there's a difference between just getting this alert and putting in an order for lung cancer screening and actually getting those patients to go and actually do the screening and then follow up on it. And that, of course, requires having that relationship and discussion with the patient so that they trust that you have their best interests. Dr. Cheryl Czerlanis: Exactly. I think that's important. You know, certainly, while technology can aid in bringing patients in, there really is no substitute for trust-building and a personal relationship with a provider. Dr. Nate Pennell: I know that there are probably multiple examples within the U.S. where health systems or programs have put together, I would say, quality improvement projects to try to increase lung cancer screening and working with their community. There's one in particular that you discuss in your paper called the "End Lung Cancer Now" initiative. I wonder if you could take us through that. Dr. Cheryl Czerlanis: Absolutely. "End Lung Cancer Now" is an initiative at the Indiana University Simon Comprehensive Cancer Center that has the vision to end suffering and death from lung cancer in Indiana through education and community empowerment. We discuss this as a paradigm for how community engagement is important in building and scaling a lung cancer screening program.  In 2023, the "End Lung Cancer Now" team decided to focus its efforts on scaling and transforming lung cancer screening rates in Indiana. They developed a task force with 26 experts in various fields, including radiology, pulmonary medicine, thoracic surgery, public health, and advocacy groups. The result of this work is an 85-page blueprint with key recommendations that any system and community can use to scale lung cancer screening efforts. After building strong infrastructure for lung cancer screening at Indiana University, they sought to understand what the priorities, resources, and challenges in their communities were. To do this, they forged strong partnerships with both local and national organizations, including the American Lung Association, American Cancer Society, and others. In the first year, they actually tripled the number of screening low-dose CTs performed in their academic center and saw a 40% increase system-wide. One thing that I think is the most striking is that through their community outreach, they learned that most people prefer to get medical care close to home within their own communities. Establishing a way to support the local infrastructure to provide care became far more important than recruiting patients to their larger system.  In exciting news, "End Lung Cancer Now" has partnered with the IU Simon Comprehensive Cancer Center and IU Health to launch Indiana's first and only mobile lung screening program in March of 2025. This mobile program travels around the state to counties where the highest incidence of lung cancer exists and there is limited access to screening. The mobile unit parks at trusted sites within communities and works in partnership, not competition, with local health clinics and facilities to screen high-risk populations. Dr. Nate Pennell: I think that sounds like a great idea. Screening is such an important thing that it doesn't necessarily have to be owned by any one particular health system for their patients. I think. And I love the idea of bringing the screening to patients where they are. I can speak to working in a regional healthcare system with a main campus in the downtown that patients absolutely hate having to come here from even 30 or 40 minutes away, and they'd much rather get their care locally. So that makes perfect sense.  So, under the current guidelines, there are certainly things that we can do to try to improve capturing the people that meet those. But are those guidelines actually capturing enough patients with lung cancer to make a difference? There certainly are proposals within patient advocacy communities and even other countries where there's a large percentage of non-smokers who perhaps get lung cancer. Can we expand beyond just older, current and heavy smokers to identify at-risk populations who could benefit from screening? Dr. Cheryl Czerlanis: Yes, I think we can, and it's certainly an active area of research interest. We know that tobacco is the leading cause of lung cancer worldwide. However, other risk factors include secondhand smoke, family history, exposure to environmental carcinogens, and pulmonary diseases like COPD and interstitial lung disease. Despite these known associations, the benefit of lung cancer screening is less well elucidated in never-smokers and those at risk of developing lung cancer because of family history or other risk factors. We know that the eligibility criteria associated with our current screening guidelines focus on age and smoking history and may miss more than 50% of lung cancers. Globally, 10% to 25% of lung cancer cases occur in never-smokers. And in certain parts of the world, like you mentioned, Nate, such as East Asia, many lung cancers are diagnosed in never-smokers, especially in women. Risk-prediction models use specific risk factors for lung cancer to enhance individual selection for screening, although they have historically focused on current or former smokers.  We know that individuals with family members affected by lung cancer have an increased risk of developing the disease. To this end, several large-scale, single-arm prospective studies in Asia have evaluated broadening screening criteria to never-smokers, with or without additional risk factors. One such study, the Taiwan Lung Cancer Screening in Never-Smoker Trial, was a multicenter prospective cohort study at 17 medical centers in Taiwan. The primary outcome of the TALENT trial was lung cancer detection rate. Eligible patients aged 55 to 75 had either never smoked or had a light and remote smoking history. In addition, inclusion required one or more of the following risk factors: family history of lung cancer, passive smoke exposure, history of TB or COPD, a high cooking index, which is a metric that quantifies exposure to cooking fumes, or a history of cooking without ventilation. Participants underwent low-dose CT screening at baseline, then annually for 2 years, and then every 2 years for up to 6 years. The lung cancer detection rate was 2.6%, which was higher than that reported in the NLST and NELSON trials, and most were stage 0 or I cancers. Subsequently, this led to the Taiwan Early Detection Program for Lung Cancer, a national screening program that was launched in 2022, targeting 2 screening populations: individuals with a heavy history of smoking and individuals with a family history of lung cancer.  We really need randomized controlled trials to determine the true rates of overdiagnosis or finding cancers that would not lead to morbidity or mortality in persons who are diagnosed, and to establish whether the high lung detection rates are associated with a decrease in lung cancer-related mortality in these populations. However, the implementation of randomized controlled low-dose CT screening trials in never-smokers has been limited by the need for large sample sizes, lengthy follow-up, and cost.  In another group potentially at higher risk for developing lung cancer, the role of lung cancer screening in individuals who harbor germline pathogenic variants associated with lung cancer also needs to be explored further. Dr. Nate Pennell: We had this discussion when the first criteria came out because there have always been risk-based calculators for lung cancer that certainly incorporate smoking but other factors as well and have discussion about whether we should be screening people based on their risk and not just based on discrete criteria such as smoking. But of course, the insurance coverage for screening, you have to fit the actual criteria, which is very constrained by age and smoking history. Do you think in the U.S. there's hope for broadening our screening beyond NLST and NELSON criteria? Dr. Cheryl Czerlanis: I do think at some point there is hope for broadening the criteria beyond smoking history and age, beyond the criteria that we have typically used and that is covered by insurance. I do think it will take some work to perhaps make the prediction models more precise or to really understand who can benefit. We certainly know that there are many patients who develop lung cancer without a history of smoking or without family history, and it would be great if we could diagnose more patients with lung cancer at an earlier stage. I think this will really count on there being some work towards trying to figure out what would be the best population for screening, what risk factors to look for, perhaps using some new technologies that may help us to predict who is at risk for developing lung cancer, and trying to increase the group that we study to try and find these early-stage lung cancers that can be cured. Dr. Nate Pennell: Part of the reason we, of course, try to enrich our population is screening works better when you have a higher pretest probability of actually having cancer. And part of that also is that our technology is not that great. You know, even in high-risk patients who have CT scans that are positive for a screen, we know that the vast majority of those patients with lung nodules actually don't have lung cancer. And so you have to follow them, you have to use various models to see, you know, what the risk, even in the setting of a positive screen, is of having lung cancer.  So, why don't we talk about some newer tools that we might use to help improve lung cancer screening? And one of the things that everyone is super excited about, of course, is artificial intelligence. Are there AI technologies that are helping out in early detection in lung cancer screening? Dr. Cheryl Czerlanis: Yes, that's a great question. We know that predicting who's at risk for lung cancer is challenging for the reasons that we talked about, knowing that there are many risk factors beyond smoking and age that are hard to quantify. Artificial intelligence is a tool that can help refine screening criteria and really expand screening access. Machine learning is a form of AI technology that is adept at recognizing patterns in large datasets and then applying the learning to new datasets. Several machine learning models have been developed for risk stratification and early detection of lung cancer on imaging, both with and without blood-based biomarkers. This type of technology is very promising and can serve as a tool that helps to select individuals for screening by predicting who is likely to develop lung cancer in the future.  A group at Massachusetts General Hospital, represented in our group for this paper by my co-authors, Drs. Fintelmann and Chang, developed Sybil, which is an open-access 3D convolutional neural network that predicts an individual's future risk of lung cancer based on the analysis of a single low-dose CT without the need for human annotation or other clinical inputs. Sybil and other machine learning models have tremendous potential for precision lung cancer screening, even, and perhaps especially, in settings where expert image interpretation is unavailable. They could support risk-adapted screening schedules, such as varying the frequency and interval of low-dose CT scans according to individual risk and potentially expand lung cancer screening eligibility beyond age and smoking history. Their group predicts that AI tools like Sybil will play a major role in decoding the complex landscape of lung cancer risk factors, enabling us to extend life-saving lung cancer screening to all who are at risk. Dr. Nate Pennell: I think that that would certainly be welcome. And as AI is working its way into pretty much every aspect of life, including medical care, I think it's certainly promising that it can improve on our existing technology.  We don't have to spend a lot of time on this because I know it's a little out of scope for what you covered in your paper, but I'm sure our listeners are curious about your thoughts on the use of other types of testing beyond CT screening for detecting lung cancer. I know that there are a number of investigational and even commercially available blood tests, for example, for detection of lung cancer, or even the so-called multi-cancer detection blood tests that are now being offered, although not necessarily being covered by insurance, for multiple types of cancer, but lung cancer being a common cancer is included in that. So, what do you think? Dr. Cheryl Czerlanis: Yes, like you mentioned, there are novel bioassays such as blood-based biomarker testing that evaluate for DNA, RNA, and circulating tumor cells that are both promising and under active investigation for lung cancer and multi-cancer detection. We know that such biomarker assays may be useful in both identifying lung cancers but also in identifying patients with a high-risk result who should undergo lung cancer screening by conventional methods. Dr. Nate Pennell: Anything that will improve on our rate of screening, I think, will be welcome. I think probably in the future, it will be some combination of better risk prediction and better interpretation of screening results, whether those be imaging or some combination of imaging and biomarkers, breath-based, blood-based. There's so much going on that it is pretty exciting, but we're still going to have to overcome the stigma and lack of public support for lung cancer screening if we're going to move the needle. Dr. Cheryl Czerlanis: Yes, I think moving the needle is so important because we know lung cancer is still a very morbid disease, and our ability to cure patients is not where we would like it to be. But I do believe there's hope. There are a lot of motivated individuals and groups who are passionate about lung cancer screening, like myself and my co-authors, and we're just happy to be able to share some ways that we can overcome the challenges and really try and make an impact in the lives of our patients. Dr. Nate Pennell: Well, thank you, Dr. Czerlanis, for joining me on the By the Book Podcast today and for all of your work to advance care for patients with lung cancer. Dr. Cheryl Czerlanis: Thank you, Dr. Pennell. It's such a pleasure to be with you today. Thank you. Dr. Nate Pennell: And thank you to our listeners for joining us today. You'll find a link to Dr. Czerlanis' article in the transcript of this episode.  Please join us again next month for By the Book's next episode and more insightful views on topics you'll be hearing at the education sessions from ASCO meetings throughout the year, and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:     Dr. Nathan Pennell    @n8pennell   @n8pennell.bsky.social Dr. Cheryl Czerlanis Follow ASCO on social media:     @ASCO on X (formerly Twitter)     ASCO on Bluesky    ASCO on Facebook     ASCO on LinkedIn     Disclosures:    Dr. Nate Pennell:        Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron       Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi    Dr. Cheryl Czerlanis: Research Funding (Institution): LungLife AI, AstraZeneca, Summit Therapeutics

Wellness in Practice: Small Steps with Big Impacts  Evaluation and Credit:  https://www.surveymonkey.com/r/medchat79 Target AudienceThis activity is targeted toward primary care physicians and advanced providers. Statement of Need Physicians often face challenges in effectively counseling patients on lifestyle changes due to time constraints and lack of training in behavior change techniques. Addressing these gaps is crucial for improving patient outcomes and overall health. By focusing on small, manageable steps, physicians can make a significant difference in their patients' lives without overwhelming them. This podcast will highlight the importance of how providers can recommend manageable changes to their daily habits that can lead to significant long-term health improvements. Objectives Identify small, evidence-based lifestyle changes that can significantly impact patient health outcomes. Describe strategies to incorporate wellness advice into routine clinical visits efficiently, even within time constraints. Recognize common barriers patients face when making lifestyle changes and develop strategies to address these challenges. List actionable steps that providers can take in their own lives to improve their wellness. Moderator James Jennings, M.D., MBA Executive Medical Director Norton Medical Group Louisville, Kentucky SpeakerEvelyn Montgomery Jones, M.D., FAADDermatologistWellSprings DermatologyPaducah, Kentucky2025 PresidentKentucky Medical Association Moderator, Speaker and Planner Disclosures  The planners, moderator and speaker of this activity do not have any relevant financial relationships with ineligible companies to disclose.  Commercial Support  There was no commercial support for this activity. GrantThis episode is supported by a grant from the Kentucky Medical Association's ‘Small STEPS, Big Impact' campaign, a two-year initiative that encourages patients to achieve long-term success through taking simple steps that can add up to make a big impact on their health. The campaign focuses on five key areas (screenings, tobacco use, exercise & nutrition, physician visits and stress) and offers straightforward strategies and support for patients. It is a partnership between the KMA and its charitable arm, the Kentucky Foundation for Medical, made possible by a grant from the Kentucky Department for Public Health. For more information, visit SmallSTEPSKy.org.   Physician CreditsAccreditationNorton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians. DesignationNorton Healthcare designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nursing CreditsNorton Healthcare Institute for Education and Development is approved as a provider of nursing continuing professional development by the South Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This continuing professional development activity has been approved for 0.75 ANCC CE contact hours. In order for nursing participants to obtain credits, they must claim attendance by attesting to the number of hours in attendance.  For more information related to nursing credits, contact Sally Sturgeon, DNP, RN, SANE-A, AFN-BC at (502) 446-5889or sally.sturgeon@nortonhealthcare.org. Resources for Additional Study/Referenceshttps://lifestylemedicine.org/ SmallSTEPSKy.org Supporting Professionals in Critical Care Medicine: Burnout, Resiliency, and System-Level Changehttps://pubmed.ncbi.nlm.nih.gov/36116823/ Battling Burnout: Strategies for Promoting Physician Wellnesshttps://pubmed.ncbi.nlm.nih.gov/30053918/   Date of Original Release | June 2025; Information is current as of the time of recording.Course Termination Date | June 2028Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org This episode is supported by a grant from the Kentucky Medical Association's ‘Small STEPS, Big Impact' campaign, a two-year initiative that encourages patients to achieve long-term success through taking simple steps that can add up to a big impact on their health. The campaign focuses on five key areas (Screenings, Tobacco use, Exercise & Nutrition, Physician visits, and Stress) and offers straightforward strategies and support for patients. It is a partnership between the KMA and its charitable arm, the Kentucky Foundation for Medical, made possible by a grant from the Kentucky Department for Public Health. For more information, visit SmallSTEPSKy.org.  Also listen to Norton Healthcare's podcast Stronger After Stroke. This podcast, produced by the Norton Neuroscience Institute, discusses difficult topics, answers frequently asked questions and provides survivor stories that provide hope. Norton Healthcare, a not for profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. More information about Norton Healthcare is available at NortonHealthcare.com.  

This week, Brandon and Chelsea Cruz from Our Reel Relationships Podcast join me to review the latest Mission: Impossible film, The Final Reckoning in a feature review and then, in this week's secondary review, I share my non-spoiler thoughts on Jesse Armstrong's Mountainhead. We also discuss recent movie and TV news, screenings around Indianapolis, and more.   Timestamps Show Start - 00:28 Introducing Brandon and Chelsea - 02:18 Screening in Indy - 19:42 News Before the Reviews - 26:18 Feature Review Mission: Impossible - The Final Reckoning (2025) - 37:15 Spoiler - 1:25:12 Secondary Review Mountainhead (2025) - 2:06:32   Closing the Ep - 2:21:48 Patreon Clip - 2:22:46   Related Links Jonathan Joss, ‘King of the Hill' Actor Who Voiced John Redcorn, Dies in Shooting at 59 Statement from Tristan Kern de Gonzales, Husband of Jonathan Joss Ridley Scott Says ‘I've Done Enough' With ‘Alien,' Thought ‘F— That's the End of the Franchise' After Bad Sequels: This Series ‘Should Be as Important' as ‘Star Wars'   My 2025 Podcast and Writing Archive Patreon Special - 28 Days Later (2002) at Alamo Drafthouse - May 23, 2025 Immediate Reaction - Clown in a Cornfield (2025) - May 16-21, 2025 Immediate Reaction - The Life of Chuck (2025) - May 29, 2025 Patreon Companion Episodes Collection Companion Ep - OV477 - Final Destination 1-5 Retrospective - May 24-25, 2025 Patreon - Severance Episode Reviews   Our Reel Relationships Podcast Apathetic Enthusiasm Interdimensional RSS Submitted for Your Approval   Indianapolis Theaters Alamo Drafthouse Indy Kan-Kan  Living Room Theaters Keystone Art  Flix Brewhouse   Ways to Support Us Support Us on Patreon for Exclusive Content Official OV Merch Buy Me A Coffee Obsessive Viewer Obsessive Viewer Presents: Anthology Obsessive Viewer Presents: Tower Junkies As Good As It Gets - Linktree Start Your Podcast with Libsyn Using Promo Code OBSESS   Follow Us on Social Media My Letterboxd | YouTube | Facebook | Twitter Instagram | Threads | Bluesky | TikTok | Tiny's Letterboxd   Mic Info Matt: ElectroVoice RE20 into RØDEcaster Pro II (Firmware: 1.5.4) Brandon: Sennheiser AT897 into RØDEcaster Pro II (Firmware: 1.5.4) Chelsea: RØDE Podmic RØDEcaster Pro II (Firmware: 1.5.4)   Episode Homepage: ObsessiveViewer.com/OV478   Next Week on the Podcast OV479 - How to Train Your Dragon (2025) & Echo Valley (2025)  

We watch a movie about dying your hair, painting your car, and trying desperately to do your job when everyone wants to get in your business.Check out our letterboxd list if you'd like to see all the movies covered that way! Send us any email questions and comments about the movies we cover or movies in general to abnormalmappingpodcast@gmail.com! Also, we're a patreon supported show, please go to patreon.com/abnormalmapping to see our many shows and support us.Next Time on Repertory Screenings: My Own Private Idaho

Episode 193: Gestational Diabetes IntroJesica Mendoza (OMSIII) describes the pathophysiology of gestational diabetes and the right timing and method of screening for it. Dr. Arreaza adds insight into the need for culturally-appropriate foods, such as vegetables in Mexican cuisine.    Written by Jesica Mendoza, OMSIII, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. Editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.DefinitionGestational diabetes mellitus (GDM) is a condition that occurs to previously non-diabetic pregnant women, caused by glucose intolerance at around the 24th week of gestation. PathophysiologyGDM arises due to an underlying pancreatic beta cell dysfunction in the mother which leads to a decrease in the amount of insulin produced and thus leads to higher blood sugar levels during pregnancy. The placenta of the fetus will produce hPL (human placental lactogen) to ensure a steady supply of sugars to the fetus, creating an anti-insulin effect. However, hPL readily crosses the placental barrier causing the mothers insulin requirement to increase, when the mother's pancreas cannot increase production of insulin to that level needed to counter the effect of hPL they become diabetic, and this leads to gestational diabetes. So, basically the placenta is asking for more glucose for the baby and the mother's pancreas struggles to keep the glucose level within normal limits in the body of the mother. If left untreated, high levels of glucose in the mother can cause glucotoxicity in the mother.“Glucotoxicity” refers to the toxic effect of glucose. Glucose is the main fuel for cell functions, but when it is high in the bloodstream, it causes toxicity to organs. Prevalence of GDM.The CDC reports mean prevenance of GDM is 6.9%. In U.S. mothers the prevenance increased from 6.0% in 2016 to 8.3% in 2021. Many different factors have played a role in increasing gestational diabetes in American mothers, some of those being the ongoing obesity epidemic with excess body weight being a known risk factor for insulin resistance. Another being advanced maternal age (AMA) as more American women have children later in life their body becomes less sensitive to insulin and requires a higher insulin output on top of the insulin that is required for the fetus. The “American diet” is also something that has a big effect in diabetes development. With the increase of high-carb foods that are readily available, the diet of Americans has declined and is affecting the metabolic health of mothers as they carry and deliver their children. Despite ongoing awareness of GDM, 6% to 9% of pregnant women in the United States are diagnosed with gestational diabetes, and the prevalence continues to increase worldwide. It is estimated that in 2017 18.4 million pregnancies were affected by GDM in the world, which then continued to increase to 1 in 6 births to women with GDM in 2019. It was also found that women living in low-income communities were disproportionately affected due to limited healthcare access. Additionally, women with GDM had a 1.4-fold increase in likelihood of undergoing a c-section, with 15% increase in risk of requiring blood transfusion. Screening for GDMGestational diabetes is screened between the 24th to 28th week of gestation in all women without known pregestational diabetes. In women who have high-risk for GDM the screening occurs during the first trimester, these women usually have at least one of the following: BMI > 30, prior history of GDM, known impaired glucose metabolism, and/or a strong family history of diabetes. The screening during the first trimester is to detect “pregestational diabetes” because we have to keep a good glycemic control to improve outcomes of pregnancy. So, if it's positive, you start treatment immediately. If these women are found to have a normal glucose, they repeat the testing again as done normally, at 24-28 weeks of gestation. How do we screen?The screening itself consists of two types of approaches. The two-step approach includes a 50-gram oral glucose tolerance test (OGTT), where blood glucose is measured in an hour and if it is below 140 they are considered to not have GDM, however if the reading is greater than 140 they must then do a 3-hour, 100g oral glucose tolerance test. The 3-hour OGTT includes measuring the blood sugars at Fasting which should be less than 95, at 1 hour at less than 180, at 2 hours at less than 155, and at 3 hours at less than 140. If 2 or more of these values exceed the threshold the patient is diagnosed with gestational diabetes mellitus. The one-step approach includes 75g after an overnight fast. Blood glucose is measured while fasting which should be less than 92, at 1 hour less than 180 and at 2 hours less than 153. If any one of these values is exceeded, the patient is diagnosed with GDM.If the mother is found to be GDM positive during pregnancy she will also need continued screening post-partum to monitor for any development of overt diabetes. The testing is usually 75g 2-hour OGTT at 6-12 weeks postpartum. If this testing is normal, then they are tested using HbA1c every 3 years. If the post-partum testing shows pre-diabetes, annual testing is recommended using HbA1c measurements. Maternal complications Women with GDM are at an increased risk for future cardiovascular disease, T2DM, and chronic kidney disease. GDM is also associated with increased likelihood of developing pre-eclampsia following delivery. Pre-eclampsia is a complication seen in pregnancy characterized by high blood pressure, proteinuria, vision changes, and liver involvement (high LFTs). Pre-eclampsia can then progress to eclampsia or HELLP syndrome, both of which can include end organ damage. Additionally, she can develop polyhydramnios which leads to overstretching of the uterus and can induce pre-term labor, placental abruption, and or uterine atony, all of which additionally put the mother at increased risk for c-section. All of these maternal complications that stem from GDM lead to complications and extended hospitalization. Child's complications Although there is an increased set of risks for the mother, the neonate can also develop a variety of risks due to the increased glucose while in utero. While the fetus is growing, the placenta is the source of nutrition for the fetus. As the levels of glucose in the mother increase so does the amount of glucose filtered through the placenta and into the fetal circulation. Over time the glucose leads to oxidative stress and inflammation with activation of TGF-b which leads to fibroblast activation and fibrosis of the placenta. This fibrosis decreases the nutrient and oxygen exchange for the fetus. As the fetus attempts to grow in this restrictive environment its development is affected. The fetus can develop IUGR (intrauterine growth restriction) leading to a small for gestation age newborn which can then lead to another set of complications. The low oxygen environment can lead to increased EPO production and polycythemia at birth which can then lead to increased clotting that can travel to the newborn brain. Newborns can also be born with fetal acidosis due to the anerobic metabolism and lactic acid buildup in fetal tissues which can cause fetal encephalopathy leading to cerebral palsy and developmental delay. And the most severe of newborn complications to gestational diabetes can lead to fetal demise. Furthermore, the increase of glucose can also lead to macrosomia in the infant which can often lead to a traumatic delivery and delivery complications such as shoulder dystocia and brachial plexus injury. Brachial plexus injury sometimes resolves without sequela, but other times can lead to permanent weakness or paralysis of the affected arm. The baby can be born too small or too big.Additionally, once the fetus is born the cutting of the umbilical cord leads to a rapid deceleration in blood glucose in the fetal circulation and hypoglycemic episodes can occur, that often lead to NICU admission. The insulin that is created by the fetus in utero to accommodate the large quantities of glucose is known to affect lung maturation as well. The insulin produced inhibits surfactant production in the fetus. Upon birth some of the newborns also have to be placed on PEEP for ventilation and some children require treatment with surfactant to prevent alveolar collapse and/or progression to NRDS created by the low surfactant levels. Additionally, neonates who are macrosomic, which is usually seen in GDM mothers, are larger and stronger and when put on PEEP to help increase ventilation the newborn's stronger respiratory effort can lead to higher pulmonary pressures and barotrauma such as neonatal pneumothorax.Long term complications to the child of a mother with GDM also occur. As the child grows, they are also at an increased risk for developing early onset obesity because of the increased adipose storage triggered by the increase in insulin in response to the high glucose in utero. This then can lead to a higher chance of developing type 2 diabetes mellitus in the child. With diabetes, also comes an increase in cardiovascular risk as the child ages and becomes an adult. The effects of GDM go beyond the fetal life but continue through adulthood.What can be done?Gestational Diabetes Mellitus has many severe and lifelong consequences for both the mother and the child and prevention of GDM would help enhance the quality of life of both. Many of the ways to prevent GDM complications include patient education and dietary modifications with a diet rich in whole grains, fruits, vegetables and lean proteins. Benefits of some vegetables in the Mexican cuisine that may be beneficial: Nopales, Chayote, and Jicama. Those are good alternatives for highly processed carbs.Mothers are usually offered nutritional counseling to help them develop a tailored eating plan. This and 30 minutes of moderate exercise daily is recommended to increase insulin sensitivity and lower the post-prandial glucose levels. If within 2 weeks of implementing lifestyle changes alone the glucose measurements remain high, then medications like insulin can be put onboard to manage the GDM. If they require insulin, I think it is time to refer to a higher level of care, if available, high risk OB clinic.Conclusion: Now we conclude episode number ###, “[TITLE].” [summary here]. _____________________References:Eades CE, Burrows KA, Andreeva R, Stansfield DR, Evans JM. Prevalence of gestational diabetes in the United States and Canada: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024 Mar 15;24(1):204. doi: 10.1186/s12884-024-06378-2. PMID: 38491497; PMCID: PMC10941381. https://pubmed.ncbi.nlm.nih.gov/38491497/QuickStats: Percentage of Mothers with Gestational Diabetes,* by Maternal Age — National Vital Statistics System, United States, 2016 and 2021. Weekly / January 6, 2023 / 72(1);16. https://www.cdc.gov/mmwr/volumes/72/wr/mm7201a4.htm?utmAkinyemi OA, Weldeslase TA, Odusanya E, Akueme NT, Omokhodion OV, Fasokun ME, Makanjuola D, Fakorede M, Ogundipe T. Profiles and Outcomes of Women with Gestational Diabetes Mellitus in the United States. Cureus. 2023 Jul 4;15(7):e41360. doi: 10.7759/cureus.41360. PMID: 37546039; PMCID: PMC10399637. https://pmc.ncbi.nlm.nih.gov/articles/PMC10399637/?utmPerlman, J. M. (2006). Summary proceedings from the neurology group on hypoxic-ischemic encephalopathy. Pediatrics, 117(3), S28–S33.DOI: 10.1542/peds.2005-0620C.Low, J. A. (1997). Intrapartum fetal asphyxia: definition, diagnosis, and classification. American Journal of Obstetrics and Gynecology, 176(5), 957–959.DOI: 10.1016/S0002-9378(97)70609-0.Hallman, M., Gluck, L., & Liggins, G. (1985). Role of insulin in delaying surfactant production in the fetal lung. Journal of Pediatrics, 106(5), 786–790.DOI: 10.1016/S0022-3476(85)80227-0.Sweet, D. G., Carnielli, V., Greisen, G., et al. (2019). European Consensus Guidelines on the Management of Respiratory Distress Syndrome – 2019 Update. Neonatology, 115(4), 432–450.DOI: 10.1159/000499361.Raju, T. N. K., et al. (1999). Respiratory distress in term infants: when to suspect surfactant deficiency. Pediatrics, 103(5), 903–909.DOI: 10.1542/peds.103.5.903.Burns, C. M., Rutherford, M. A., Boardman, J. P., & Cowan, F. M. (2008). Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycemia. Pediatrics, 122(1), 65–74.DOI: 10.1542/peds.2007-2822.Dabelea, D., et al. (2000). Long-term impact of maternal diabetes on obesity in childhood. Diabetes Care, 23(10), 1534–1540.DOI: 10.2337/diacare.23.10.1534.Dashe, J. S., et al. (2002). "Hydramnios: Etiology and outcome." Obstetrics & Gynecology, 100(5 Pt 1), 957–962.DOI: 10.1016/S0029-7844(02)02279-6.Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to prevent gestational diabetes mellitus: a decision-analytic modelling study. Diabetologia.American College of Obstetricians and Gynecologists. (2018). Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstetrics & Gynecology, 131(2), e49–e64. https://doi.org/10.1097/AOG.0000000000002501Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Can we trust the Fantastic Four test screening reports? Let's break down the rumors! It's time for another episode of THE RUMOR RUNDOWN, New Rockstars' weekly show where we break down the top trending rumors in the nerd world. This week, Erik Voss and Jessica Clemons go through the rumored reports of Fantastic Four test screenings and breakdown some more supposed X-Men casting details! Written by: Erik Voss, Jessica Clemons Head of Content & Executive Producer: Erik Voss General Manager: Zach Huddleston Head of Production: John Costa Director of Programming: Brandon Barrick Senior Producer: Jessica Clemons Producer: Gina Ippolito Staff Editors: Abby Freel & Joshua Steven Hurd Editors: Brian M Kim Studio Techs: Brian M Kim Researcher: Noah Chen For business inquiries please contact business@nrdigitalstudios.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

"I'm going to steal the Declaration of Independence." - Benjamin Gates   Welcome to episode 227! Infinity Bros Isaac and Mark bring a jam packed FUN episode to your earholes, with some Nerd News, Hot/Snot, and our Top 6 Nicolas Cage movies! Mark ponders the future of the MCU with Fantastic 4 on the horizon, while Isaac gushes about his favorite Cage classics. It's a classic Mark and Isaac mess around!   And HUGE congrats to the newlyweds, Infinity Bro Zayne and his beautiful bride Annika!   Join us for a fantastic, fun-filled conversation!   Check out the Infinity Bros Patreon for EXCLUSIVE content, including unedited episodes, exclusive podcasts, and more!   Infinity Bro Robbie has gone SOLO with his MTG career! Check out his new profile here: Robert Red Beard MTG   Want to connect with the Infinity Bros Universe? Click this link --> https://linktr.ee/infinitybros   Hear our reviews of 'Thunderbolts*' and 'Sinners' on episode 226 of the Infinity Bros Podcast HERE!   Check out our review of 'Daredevil: Born Again' on episode 225 of the Infinity Bros Podcast HERE!   Listen to our review of season 2 of 'Severance' on episode 223 of the Infinity Bros Podcast HERE!   Hear our review of 'Your Friendly Neighborhood Spider-Man' on episode 221 of the Infinity Bros Podcast HERE!   Check out our 'Captain America: Brave New World' review on episode 220 of the Infinity Bros Podcast HERE!   Listen to our 2024 StanLee Awards show where we ranked our Top 6 Movies and TV Shows of 2024 HERE!   Check out our review of 'Skeleton Crew' on episode 217 of the Infinity Bros Podcast HERE!   Hear our review of 'The Penguin' on episode 214 of the Infinity Bros Podcast HERE!   Get some delicious coffee or tea from Many Worlds Tavern here, and get 10% off by using code THEINFINITYBROS!   Order your favorite character's Funko Pop at Entertainment Earth here, and get 10% off by using code INFINITY!   Check out all of RIPT Apparel's awesome t-shirt designs here!   Cover Art Artist: Jack Baumert (@Jack_baumertart on Instagram)

What do test screenings and reshoots mean for Superman and Fantastic Four? Chris Gore and Alan Ng are joined by The Angry Badger, Verbal Riot, Steph from My Nerdy Home, Derek Anderson and Robert Meyer Burnett. Hilarity ensues!

Did you know that Obsessive-Compulsive Disorder (OCD) affects approximately 1 in 200 children, with symptoms often emerging between the ages of 7 and 12? As pediatricians, you're likely the first to encounter these patients, making early recognition and intervention critical for achieving optimal outcomes. In this episode, we'll provide you with the knowledge and tools needed to accurately diagnose and effectively manage OCD, laying the foundation for better long-term care. Dr. Theresa Fiagbe, a second-year Child Psychiatry Fellow, Dr. Dale Peeples, Associate Professor of Child Psychiatry, and Alisha Patel, Medical Student at the Medical College of Georgia, join forces to unpack the complexities of OCD in children and adolescents. Tune in as we: Explore key diagnostic criteria and the most effective screening tools for identifying OCD in pediatric patients Discuss evidence-based treatments such as Cognitive Behavioral Therapy (CBT) and SSRIs, and how to incorporate them into your practice Review common comorbid conditions, like anxiety and PANDAS, that can complicate diagnosis and treatment Examine the impact of OCD on school performance, social interactions, and family life Share practical guidance on managing long-term care to prevent relapse and ensure successful outcomes Whether you're encountering OCD symptoms in a patient for the first time or seeking to enhance your expertise, this episode will equip you with the essential tools to improve diagnosis and treatment. Special thanks to Dr. Yang for editing and Dr. Sarah Straka, and Dr. Baris Olten for peer reviewing this episode. CME Credit Available: Link Coming Soon! References: American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. Berman, L., & Flessner, C. A. (2014). Pediatric obsessive-compulsive disorder: Diagnostic and treatment issues. Journal of the American Academy of Child and Adolescent Psychiatry, 53(2), 123-131. https://doi.org/10.1016/j.jaac.2013.10.003 Clark, C. A., & Scharf, R. (2020). Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents: Current trends and future directions. Journal of the American Academy of Child and Adolescent Psychiatry, 59(9), 971-979. https://doi.org/10.1016/j.jaac.2020.05.007 Fahrion, S., & Goodwin, G. M. (2019). Pharmacological treatment of pediatric obsessive-compulsive disorder: SSRIs, clomipramine, and beyond. Current Psychiatry Reports, 21(8), 58-66. https://doi.org/10.1007/s11920-019-1040-3 Franklin, M. E., & March, J. S. (2015). Treatment of obsessive-compulsive disorder in children and adolescents. Pediatric Clinics of North America, 62(3), 529-545. https://doi.org/10.1016/j.pcl.2015.02.004 March, J. S., & Mulle, K. (2017). OCD in children and adolescents: A review of treatments and practical guidance. The Psychiatric Clinics of North America, 40(2), 199-208. https://doi.org/10.1016/j.psc.2017.01.002 Murphy, T. K., & Pincus, D. B. (2019). Pediatric obsessive-compulsive disorder: Diagnosis, treatment, and future directions. Current Opinion in Pediatrics, 31(4), 517-524. https://doi.org/10.1097/MOP.0000000000000801 PANDA Study Group. (2017). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Journal of the American Academy of Child and Adolescent Psychiatry, 56(11), 933-940. https://doi.org/10.1016/j.jaac.2017.07.866 Peris, T. S., & Piacentini, J. (2021). Pediatric obsessive-compulsive disorder: Treatment strategies and challenges. Journal of Clinical Child and Adolescent Psychology, 50(1), 32-43. https://doi.org/10.1080/15374416.2020.1831504 Reaven, J. (2018). Screening for pediatric obsessive-compulsive disorder: Tools, guidelines, and challenges. Child and Adolescent Mental Health, 23(3), 133-139. https://doi.org/10.1111/camh.12267 Thienemann, M., & McGuire, L. (2019). Treating pediatric OCD with a focus on cognitive-behavioral therapy: Evidence and efficacy. Journal of Clinical Child and Adolescent Psychology, 48(4), 530-538. https://doi.org/10.1080/15374416.2019.1612851

On this episode of THE GEEK BYTES brought to you by The Geek Buddies, John Rocha, Michael Vogel, and Shannon McClung talk all the big news this week from DC, Star Wars and Marvel including the "mixed" reactions to the first test screenings for FANTASTIC FOUR: FIRST STEPS, more issues behind the scenes of SUPERMAN, the new cast of kids for the HARRY POTTER series, Hulk and Punisher seemingly confirmed for Spider-Man 4, Laura Linney cast in LANTERNS, new details on the DARTH MAUL series and more! Remember to Like and Share this episode on your social media and to Subscribe to The Outlaw Nation YouTube channel below. #marvel #fantasticfour #Superman #DC #HarryPotter #StarWars #thegeekbuddies ____________________________________________________________________________________ Chapters: 0:00 Intro 2:48 New Details on Darth Maul Animated Series 13:15 Harry Potter TV Series Casts Its Harry, Hermione and Ron 25:33 Laura Linney Cast in LANTERNS Series, Is She Carol Ferris? 30:28 More SUPERMAN Drama Behind the Scenes 41:26 Fantastic 4: First Steps Test Screenings are "Mixed" 55:55 Hulk and The Punisher in Spider-Man 4 Confirmed 1:02:24 Marvel is Skipping Out on Hall H at 2025 SDCC FOLLOW THE GEEK BUDDIES: Twitter: https://twitter.com/Geek_Buddies Follow John Rocha: https://twitter.com/TheRochaSays​​​​​ Follow Michael Vogel: https://twitter.com/mktoon Follow Shannon McClung: https://twitter.com/Shannon_McClung Instagram: https://www.instagram.com/the_geek_bu...

As the Trump administration moves to slash NPR's federal funding, the network and three Colorado stations have fired back with a First Amendment lawsuit. Meanwhile, Hollywood's theatrical business is booming. Memorial Day weekend raked in $326 million — up from $132 million last year — thanks to a packed release slate. Who was the biggest box office winner over the holiday weekend? Kim Masters and Matt Belloni dive in. Plus, Masters talks to veteran film analyst Kevin Goetz about pivoting from a steady career in acting to a decades long journey in entertainment research. Goetz sheds light on the science and art behind audience testing, and he and Masters swap stories from some infamous test screenings over the years.

As the Trump administration moves to slash NPR’s federal funding, the network and three Colorado stations have fired back with a First Amendment lawsuit. Meanwhile, Hollywood’s theatrical business is booming. Memorial Day weekend raked in $326 million — up from $132 million last year — thanks to a packed release slate. Who was the biggest box office winner over the holiday weekend? Kim Masters and Matt Belloni dive in.   Plus, Masters talks to veteran film analyst Kevin Goetz about pivoting from a steady career in acting to a decades long journey in entertainment research. Goetz sheds light on the science and art behind audience testing, and he and Masters swap stories from some infamous test screenings over the years.  

See omnystudio.com/listener for privacy information.

In May 2024, the FDA approved vaginal self-collection for HPV as a cervical cancer screening tool. This was limited to health care settings. While this self collection option can help address some of the emotional deterrents to a speculum examination, it fails to overcome the remaining substantial clinic access barriers cited among those who are underscreened, including time off work, arrangement of child or elder care, and transportation. Then, the FDA approved the first at-home cervical cancer screening test on May 9, 2025. This test, called the Teal Wand (FDA-approved prescription device), allows individuals to self-collect vaginal samples at home to test for Human Papillomavirus (HPV). But is at-home testing valid? Does this work? A new publication in JAMA Network Open (May 19, 2025) answers this important question. Listen in for details.